Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Donor Cell Transplants ‘Chance of Cure’ in Rare Aggressive Lymphoma
August 2026
A new study of finds allogeneic stem cell transplants offer a genuine chance of cure in rare hepatosplenic T-cell lymphoma.
Read more
18 Aug 2026
Donor Cell Transplants ‘Chance of Cure’ in Rare Aggressive Lymphoma
A new study of finds allogeneic stem cell transplants offer a genuine chance of cure in rare hepatosplenic T-cell lymphoma.
16 Aug 2026
Machine Learning Identifies CHAF1A In Burkitt Lymphoma
An integrated transcriptomic and machine-learning analysis identified CHAF1A as a candidate biomarker and potential therapeutic target in Burkitt lymphoma.
15 Aug 2026
Immune Reconstitution and Viral Reactivation After HSCT
Immune reconstitution after allogeneic HSCT showed distinct associations with CMV and EBV reactivation, while viral reactivation was not linked to survival.
11 Aug 2026
Coeliac Disease Prevalent Among Children with Anaemia
Coeliac disease was found in 17.5% of children with anaemia, while all biopsy confirmed cases had negative serology.
9 Aug 2026
Low Dose CAR-T Therapy Achieved High Remission Rates
CAR T cell therapy achieved high remission rates with manageable safety in relapsed diffuse large B cell lymphoma.
4 Aug 2026
Liberal Transfusion Reduced Myocardial Infarction Risk
A post hoc analysis suggested that a liberal transfusion strategy offered an overall clinical benefit for patients with myocardial infarction and anaemia by reducing death or recurrent myocardial infarction.
2 Aug 2026
Mismatched Donor Transplants Reduced Relapse Risk
Mismatched unrelated donor transplant associated with lower relapse rates than matched related donor transplantation in high risk blood cancers.
1 Aug 2026
Erythropoietin Not Linked to Thrombocytosis in Iron Deficiency Anaemia
A cross sectional study found that although erythropoietin levels were elevated in most patients with iron deficiency anaemia and thrombocytosis, the hormone was not associated with platelet count.
Loading posts...
1
2
3
…
53
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View